600 related articles for article (PubMed ID: 17157662)
21. Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients.
Lee JH; Chang HS; Kim JH; Park SM; Lee YM; Uh ST; Rhim T; Chung IY; Kim YH; Park BL; Park CS; Shin HD
J Allergy Clin Immunol; 2007 Nov; 120(5):1110-7. PubMed ID: 17983872
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
[TBL] [Abstract][Full Text] [Related]
23. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma.
Busse WW; Ring J; Huss-Marp J; Kahn JE
J Allergy Clin Immunol; 2010 Apr; 125(4):803-13. PubMed ID: 20371394
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic criteria for eosinophilic esophagitis: a 5-year retrospective review in a pediatric population.
Lai AL; Girgis S; Liang Y; Carr S; Huynh HQ
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):63-70. PubMed ID: 19465874
[TBL] [Abstract][Full Text] [Related]
25. Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis.
Conus S; Straumann A; Bettler E; Simon HU
J Allergy Clin Immunol; 2010 Jul; 126(1):175-7. PubMed ID: 20542323
[No Abstract] [Full Text] [Related]
26. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK; Jameson SC; Thomson B; Collins MH; Wagoner LE; Freese DK; Beck LA; Boyce JA; Filipovich AH; Villanueva JM; Sutton SA; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2004 Jan; 113(1):115-9. PubMed ID: 14699394
[TBL] [Abstract][Full Text] [Related]
27. Celiac disease and eosinophilic esophagitis: a true association.
Leslie C; Mews C; Charles A; Ravikumara M
J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):397-9. PubMed ID: 19841598
[TBL] [Abstract][Full Text] [Related]
28. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
29. Anti-interleukin-5 antibody therapy in eosinophilic diseases.
Simon D; Braathen LR; Simon HU
Pathobiology; 2005; 72(6):287-92. PubMed ID: 16582580
[TBL] [Abstract][Full Text] [Related]
30. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.
Kirsch R; Bokhary R; Marcon MA; Cutz E
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):20-6. PubMed ID: 17204948
[TBL] [Abstract][Full Text] [Related]
31. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
Oldhoff JM; Darsow U; Werfel T; Katzer K; Wulf A; Laifaoui J; Hijnen DJ; Plötz S; Knol EF; Kapp A; Bruijnzeel-Koomen CA; Ring J; de Bruin-Weller MS
Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
[TBL] [Abstract][Full Text] [Related]
32. Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice.
Mishra A; Schlotman J; Wang M; Rothenberg ME
J Leukoc Biol; 2007 Apr; 81(4):916-24. PubMed ID: 17194734
[TBL] [Abstract][Full Text] [Related]
33. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair: a case series.
Oliveira C; Zamakhshary M; Marcon P; Kim PC
J Pediatr Surg; 2008 May; 43(5):810-4. PubMed ID: 18485944
[TBL] [Abstract][Full Text] [Related]
34. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
Aceves SS; Bastian JF; Newbury RO; Dohil R
Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
[TBL] [Abstract][Full Text] [Related]
35. Childhood esophagitis: then and now.
Lee JJ; Baker RD; Khan AR; Baker SS
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):37-40. PubMed ID: 19172121
[TBL] [Abstract][Full Text] [Related]
36. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis.
Straumann A; Bussmann C; Conus S; Beglinger C; Simon HU
J Allergy Clin Immunol; 2008 Aug; 122(2):425-7. PubMed ID: 18678345
[No Abstract] [Full Text] [Related]
37. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.
Straumann A; Bauer M; Fischer B; Blaser K; Simon HU
J Allergy Clin Immunol; 2001 Dec; 108(6):954-61. PubMed ID: 11742273
[TBL] [Abstract][Full Text] [Related]
38. [Primary eosinophilic esophagitis].
Høyerup P; Svendsen LB; Mogensen AM; Staun M
Ugeskr Laeger; 2006 Jan; 168(3):291-2. PubMed ID: 16430818
[TBL] [Abstract][Full Text] [Related]
39. Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia.
Ngo P; Furuta GT; Antonioli DA; Fox VL
Am J Gastroenterol; 2006 Jul; 101(7):1666-70. PubMed ID: 16863575
[TBL] [Abstract][Full Text] [Related]
40. Eosinophilic esophagitis and Barrett's esophagus: an occasional association or an overlap disease? Esophageal 'double trouble' in two children.
Francalanci P; De Angelis P; Minnei F; Diomedi Camassei F; Torroni F; Dall'Oglio L; Callea F
Digestion; 2008; 77(1):16-9. PubMed ID: 18253045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
